<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">ANTI-INFLAMMATORY PROPERTIES OF NAP IN ACUTE TOXOPLASMA GONDII-INDUCED ILEITIS IN MICE</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Markus</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
							<email>markus.heimesaat@charite.de</email>
							<affiliation key="aff1">
								<orgName type="department">Department of Microbiology and Hygiene</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">André</forename><surname>Fischer</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Microbiology and Hygiene</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anja</forename><forename type="middle">A</forename><surname>Kühl</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine I for Gastroenterology, Infectious Disease and Rheumatology/Research Center ImmunoSciences (RCIS)</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulf</forename><forename type="middle">B</forename><surname>Göbel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Microbiology and Hygiene</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Illana</forename><surname>Gozes</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Clinical Biochemistry</orgName>
								<orgName type="institution" key="instit1">Sackler School of Medicine</orgName>
								<orgName type="institution" key="instit2">Tel Aviv University</orgName>
								<address>
									<settlement>Tel Aviv</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><surname>Bereswill</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Microbiology and Hygiene</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Microbiology and Hygiene</orgName>
								<orgName type="department" key="dep2">FEM</orgName>
								<orgName type="institution">Charité -University Medicine Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin, Garystr. 5</addrLine>
									<postCode>CC5, D-14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">ANTI-INFLAMMATORY PROPERTIES OF NAP IN ACUTE TOXOPLASMA GONDII-INDUCED ILEITIS IN MICE</title>
					</analytic>
					<monogr>
						<idno type="ISSN">2062-8633</idno>
					</monogr>
					<idno type="MD5">7104ED3C993ECE5F249F1CBF8CAE1FD6</idno>
					<idno type="DOI">10.1556/1886.2015.00025</idno>
					<note type="submission">Received: August 17, 2015; Accepted: August 23, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>NAP</term>
					<term>ADNP</term>
					<term>Toxoplasma gondii</term>
					<term>acute ileitis</term>
					<term>Th1-type immunopathology</term>
					<term>anti-inflammatory effects</term>
					<term>immunomodulatory properties</term>
					<term>gut-brain axis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The octapeptide NAP has been shown to exert neuroprotective properties.</s><s>Here, we investigated potential anti-inflammatory effects of NAP in an acute ileitis model.</s><s>To address this, C57BL/6j mice were perorally infected with Toxoplasma gondii (day 0).</s><s>Within 1 week postinfection (p.i.), placebo (PLC)-treated mice developed acute ileitis due to Th1-type immune responses.</s><s>Mice that were subjected to intraperitoneal NAP treatment from day 1 until day 6 p.i., however, developed less distinct macroscopic and microscopic disease as indicated by less body weight loss, less distinct histopathological ileal changes, and lower ileal apoptotic, but higher proliferating cell numbers, less abundance of neutrophils, macrophages, monocytes, and T lymphocytes, but higher numbers of regulatory T cells in the ileal mucosa and lamina propria, and lower concentrations of pro-inflammatory mediators in the ilea as compared to PLC controls at day 7 p.i. Remarkably, NAP-mediated anti-inflammatory effects could also be observed in extra-intestinal compartments including liver and spleen.</s><s>Strikingly, lower MCP-1, TNF, and IL-12p70 serum concentrations in NAP as compared to PLC-treated mice at day 7 p.i. indicate a pronounced systemic anti-inflammatory effect of NAP in acute ileitis.</s><s>These findings provide first evidence for NAP as a potential novel treatment option in intestinal inflammation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Within 7 days following peroral infection with 100 cysts of Toxoplasma (T.) gondii ME49 strain, C57BL/6j mice develop nonself-limiting acute ileitis <ref type="bibr" target="#b0">[1]</ref>.</s><s>This fatal infl ammatory scenario in the small intestinal tract is due to a Th1-type immunopathology orchestrated by intestinal epithelial cells, neutrophils, macrophages, monocytes, dendritic cells, and lymphocytes <ref type="bibr" target="#b1">[2]</ref>.</s><s>During the early course of T. gondii infection, parasitic interaction with antigen presenting cells results in activation of CD4+ T cells and subsequent over-production of pro-infl ammatory mediators such as TNF, MCP-1, nitric oxide (NO), IL-6, IL-12, and IFN-γ <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s><s>The underlying immunopathogenesis, thus, mimics key features of chronic infl ammatory bowel diseases (IBD) such as Crohn's disease during the acute stage <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b7">8]</ref>.</s></p><p><s>The oligopeptide NAP consists of eight amino acids (namely NAPVSIPQ) and was initially identifi ed as a bio-logically active fragment of the activity-dependent neuroprotective protein (ADNP) <ref type="bibr" target="#b8">[9]</ref>.</s><s>Besides the central nervous system, human ADNP expression could be detected in spleen, peripheral blood leukocytes, and macrophages <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s><s>The neuroprotective effects exerted by NAP have been investigated in vitro and in multiple in vivo models of neuronal injury including closed head injury, fetal alcohol syndrome, stroke, Alzheimer's disease, and neonatal hypoxia-ischemia <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>. Anti-oxidative as well as immunomodulatory actions have been proposed as potential underlying mechanisms of the benefi cial effects exerted by NAP <ref type="bibr" target="#b17">[18]</ref>.</s><s>Moreover, NAP has been shown to suppress the production of pro-infl ammatory cytokines including TNF, IL-6, and IL-12 <ref type="bibr" target="#b11">[12]</ref> that are also involved in mediating acute T. gondii-induced ileitis <ref type="bibr" target="#b1">[2]</ref>.</s><s>This prompted us to investigate potential immunomodulatory properties of synthetic NAP in an acute murine model of small intestinal infl ammation.</s><s>We here demonstrate for the fi rst time that the NAP oligopeptide is able to exert potent anti-infl ammatory effects in the infl amed intestinal tract and diminishes extra-intestinal as well as systemic collateral damages of infl ammation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics statement</head><p><s>All animal experiments were conducted according to the European Guidelines for animal welfare (2010/63/EU) and approved by the local authorities.</s><s>Animal welfare was monitored twice daily by assessment of clinical conditions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mice, T. gondii infection, and treatment</head><p><s>Female C57BL/6j wildtype control mice were included into the experiments.</s><s>For induction of acute ileitis, threemonth-old mice were infected perorally with 100 T. gondii cysts (ME49 strain) derived from homogenized brains of intraperitoneally infected NMRI mice in a volume of 0.3 ml phosphate-buffered saline (PBS) by gavage, as described previously <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>.</s><s>From day 1 until day 6 postinfection (p.i.), mice were either treated with synthetic NAP (1.0 mg per kg body weight per day) or PBS (placebo [PLC]) once daily via the intraperitoneal route.</s><s>A potential antimicrobial effect of the NAP solution was excluded as described previously <ref type="bibr" target="#b21">[22]</ref>.</s><s>Naive mice served as uninfected and untreated (None) negative controls.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sampling procedures</head><p><s>At day 7 postinfection (p.i.), mice were sacrifi ced by isofl uran treatment (Abbott, Greifswald, Germany).</s><s>Cardiac blood and tissue samples from spleen, liver, and ileum were removed under sterile conditions.</s><s>Ileal ex vivo biopsies from each mouse were collected in parallel for histopathological, immunohistochemical, microbiological, and immunological analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histopathology and immunohistochemistry</head><p><s>Immunohistopathological changes were determined in ex vivo biopsies derived from the terminal ileum that were immediately fi xed in 5% formalin and embedded in paraffi n.</s><s>Sections (5 μm) were stained with hematoxylin and eosin (H&amp;E) and examined by light microscopy (magnification 100× and 400×), and ileal histopathology was determined as described previously <ref type="bibr" target="#b18">[19]</ref>.</s></p><p><s>In situ immunohistochemical analysis of ileal paraffi n sections was performed as described earlier <ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref>.</s><s>Primary antibodies against cleaved caspase-3 (Asp175, Cell Signaling, Beverly, MA, USA, 1:200), Ki67 (TEC3, Dako, Denmark, 1:100), myeloperoxidase (MPO-7, no.</s><s>A0398, Dako, 1:500), F4/80 (no.</s><s>14-4801, clone BM8, eBiosci-ence, San Diego, CA, USA, 1:50), CD3 (no.</s><s>N1580, Dako, 1:10), and FOXP3 (FJK-16s, eBioscience, 1:100) were used.</s><s>For each animal, the average number of positively stained cells within at least six high power fi elds (HPF, 0.287 mm 2 , 400× magnifi cation) were determined microscopically by a double-blinded investigator.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Detection of ileal T. gondii DNA and cytokines</head><p><s>Ileal ex vivo biopsies were cut longitudinally and washed in PBS.</s><s>In approximately 1 cm 2 of homogenized ileal tissue, T. gondii DNA was measured as described previously <ref type="bibr" target="#b26">[27]</ref>.</s><s>Spleen, liver, or strips of approximately 1 cm 2 ileal tissue were placed in 24-fl at-bottom well culture plates (Nunc, Wiesbaden, Germany) containing 500 μl serum-free RPMI 1640 medium (Gibco, Life Technologies, Paisley, UK) supplemented with penicillin (100 U/ ml) and streptomycin (100 μg/ml; PAA Laboratories).</s><s>After 18 h at 37 °C, culture supernatants and serum samples were tested for MCP-1, TNF, IL-6, and IL-12p70 by the Mouse Infl ammation Cytometric Bead Assay (CBA; BD Biosciences) on a BD FACSCanto II fl ow cytometer (BD Biosciences).</s><s>Nitric oxide (NO) was determined by Griess reaction as described earlier <ref type="bibr" target="#b18">[19]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Medians and levels of signifi cance were determined using Mann-Whitney U test (GraphPad Prism v5, La Jolla, CA, USA) as indicated.</s><s>Two-sided probability (P) values ≤0.05 were considered signifi cant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and histopathologic outcome in NAP-treated mice following acute ileitis induction</head><p><s>In order to induce acute ileitis, mice were perorally challenged with 100 cysts of T. gondii ME49 strain by gavage on day 0. From day 1 until day 6 p.i., infected mice were either treated with synthetic NAP or PLC.</s><s>Whereas PLC control mice were suffering from wasting due to acute ileitis and a median weight loss of more than 15% at day 7 p.i., NAP-treated mice displayed better clinical conditions as indicated by a signifi cantly less pronounced weight loss of approximately 10% (p &lt; 0.0001 versus PLC; Fig. <ref type="figure">1a</ref>).</s><s>Less macroscopic disease following NAP treatment was accompanied by less distinct histopathological changes in the ileal mucosa as indicated by lower histopathological scores in NAP as compared to PLC-treated mice at day 7 following ileitis induction (p &lt; 0.05; Fig. <ref type="figure">1b</ref>).</s><s>Notably, NAP did neither have a direct antimicrobial effect that could potentially affect the composition of the intestinal microbiota nor did it exert an anti-parasitic effect as indicated by ileal T. gondii DNA loads comparable to those detected in PLC mice (Fig. <ref type="figure">1c</ref>).</s><s>Given that apoptosis is a commonly used diagnostic marker in the histopathological evaluation and grading of intestinal disease <ref type="bibr" target="#b22">[23]</ref> we quantitatively assessed numbers of caspase-3+ cells within the ileal mucosa of T. gondii-infected mice.</s><s>During ileitis development apoptotic ileal epithelial cell numbers increased (p &lt; 0.0001; Fig. <ref type="figure">2a</ref>), whereas this increase, however, was less pronounced in NAP-treated mice (p &lt; 0.0001; Fig. <ref type="figure">2a</ref>).</s></p><p><s>Since Ki67 comprizes a nuclear protein associated with and necessary for cellular proliferation <ref type="bibr" target="#b27">[28]</ref>, we also stained ileal paraffi n sections with anti-Ki67 in order to determine proliferative measures of the small intestinal epithelium counteracting apoptosis following T. gondii infection.</s><s>Only NAP-treated mice displayed elevated Ki67+ epithelial cell numbers in the ileal mucosa at day 7 p.i. as compared to naive mice (p &lt; 0.0001 vs. naive and PLC; Fig. <ref type="figure">2b</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Small intestinal immune cell responses in NAP-treated mice following acute ileitis induction</head><p><s>We next quantitatively assessed the infl ux of innate and adaptive immune as well as of effector cells into the ileal mucosa and lamina propria by in situ immunohistochemical staining of small intestinal paraffi n sections.</s><s>Seven days following ileitis induction, numbers of neutrophils, macrophages, and monocytes as well as of T lympho-cytes, the major forces driving T. gondii-induced immunopathology <ref type="bibr" target="#b28">[29]</ref>, increased in small intestines of infected mice (p &lt; 0.0001 vs. naive controls; Fig. <ref type="figure" target="#fig_1">3a-c</ref>).</s><s>These increases, however, were less distinct in NAP as compared to PLC-treated mice (p &lt; 0.0005, p &lt; 0.01, and p &lt; 0.005, respectively; Fig. <ref type="figure" target="#fig_1">3a-c</ref>).</s><s>Remarkably, only following NAP treatment increased numbers of ileal FOXP3+ regulatory T cells could be observed (p &lt; 0.05 vs. naive and PLC; Fig. <ref type="figure" target="#fig_1">3d</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ileal and extra-intestinal pro-inflammatory cytokine secretion in NAP-treated mice following acute ileitis induction</head><p><s>We next determined whether NAP treatment affected intestinal and extra-intestinal cytokine secretion in T. gondiiinfected mice.</s><s>Seven days following acute ileitis induction, increased pro-infl ammatory mediators such as MCP-1, TNF, nitric oxide (NO), and IL-6 could be measured in supernatants of ileal ex vivo biopsies as compared to na-ive controls (p &lt; 0.05-0.0001;</s><s>Fig. <ref type="figure" target="#fig_2">4</ref>).</s><s>In NAP-treated mice, however, signifi cantly lower ileal MCP-1 concentrations (p &lt; 0.05; Fig. <ref type="figure" target="#fig_2">4a</ref>) and a trend towards lower TNF and NO levels (n.s.; Fig. <ref type="figure" target="#fig_2">4b and c</ref>) could be detected as compared to PLC mice at day 7 p.i.</s><s>To address whether also extra-intestinal infl ammatory sequelae of T. gondii infection could be ameliorated by NAP treament, we determined pro-infl ammatory mediators in ex vivo liver biopsies before and after ileitis induction.</s><s>Seven days following T. gondii infection, hepatic MCP-1, TNF, NO, and IL-6 concentrations increased multifold in PLC mice (p &lt; 0.005-0.0001;</s><s>Fig. <ref type="figure" target="#fig_3">5</ref>).</s><s>In livers of NAP-treated mice, however, signifi cantly lower hepatic concentrations of respective mediators could be detected (p &lt; 0.05, p &lt; 0005, p &lt; 0.05, and p &lt; 0.005, respectively; Fig. <ref type="figure" target="#fig_3">5</ref>).</s><s>Notably, hepatic MCP-1 and NO concentration were comparable in NAP-treated and naive mice (Fig. <ref type="figure" target="#fig_3">5a and c</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Systemic pro-inflammatory cytokine secretion in NAP-treated mice following acute ileitis induction</head><p><s>For the assessment of potential systemic anti-infl ammatory effects of NAP treatment in T. gondii-infected mice, we measured pro-infl ammatory mediators in spleen and serum.</s><s>Seven days following ileitis induction, MCP-1, TNF, and NO, but not IL-6 levels, were increased in spleens of PLC control mice (Fig. <ref type="figure" target="#fig_4">6</ref>).</s><s>Remarkably, NAP-treated animals exhibited lower splenic MCP-1 and TNF concentrations as compared to PLC mice at day 7 p.i. (p &lt; 0.05 and p &lt; 0.05, respectively; Fig. <ref type="figure" target="#fig_4">6a and b</ref>), whereas MCP-1 levels were comparable in NAP-treated and naive mice (Fig. <ref type="figure" target="#fig_4">6a</ref>).</s><s>Furthermore, serum MCP-1, TNF, IL-12p70, and IL-6 concentrations increased multifold in T. gondii-infected mice of either group (Fig. <ref type="figure" target="#fig_5">7</ref>).</s><s>Strikingly, serum concentrations of the former three cytokines were lower in NAP as compared to PLC-treated mice at day 7 p.i. (p &lt; 0.05; Fig. <ref type="figure" target="#fig_5">7a-c</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Several in vitro and in vivo studies revealed that the octapeptide NAP exerts neuroprotective effects by antioxidative and immunomodulatory mechanisms <ref type="bibr" target="#b17">[18]</ref>.</s><s>For the fi rst time, we investigated here the potential benefi cial actions of NAP in an acute small intestinal infl ammation model.</s><s>Results demonstrate that NAP exerted potent antiinfl ammatory effects in acute T. gondii-induced ileitis of mice as indicated by 1) less macroscopic and microscopic disease, 2) reduced ileal apoptosis but increased mucosal cell proliferation, 3) less infl ux of pro-infl ammatory immune cells into the ileal mucosa and lamina propria, 4) less secretion of pro-infl ammatory mediators in the ileum and extra-intestinal compartment such as the liver, and 5) diminished systemic infl ammatory responses following NAP treatment.</s><s>Notably, NAP did not interfere with the T. gondii infection given that comparable parasitic DNA loads could be detected in small intestines of NAP and PLC-treated mice.</s><s>Moreover, treatment was initiated 24 h after T. gondii infection in order to avoid direct parasite-NAP interaction.</s><s>Given that the distinct intestinal microbiota composition plays a critical role in the initiation and perpetuation of immunopathological conditions <ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref>, we ruled out that NAP exerted any anti-bacterial effects in vitro.</s></p><p><s>In our study, NAP-treated mice did not only exhibit less distinct small intestinal histopathological changes including necrosis but also less pronounced apoptosis as indicated by lower numbers of caspase-3+ cells within the ileal mucosa.</s><s>In line with this, recent studies revealed that the cell survival promoting activity of NAP in the brain was due to prevention of caspase-3 activation and, hence, of apoptotic cell death <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>.</s><s>Conversely, numbers of Ki67+ cells within the ileal mucosa were increased upon NAP application here, indicative for proliferative measures of the small intestinal epithelium thereby counteracting apoptosis.</s></p><p><s>In NAP-treated mice, lower numbers of innate and adaptive as well as of effector immune cells including neutrophils exerting oxidative stress to the intestinal epithelium in the ileal mucosa and lamina propria could be observed.</s><s>Braitch et al. showed that monocytes, T and B cells, but not regulatory T cells (Tregs) derived from peripheral blood mononuclear cells (of healthy blood donors) expressed ADNP <ref type="bibr" target="#b17">[18]</ref>.</s><s>The better outcome in NAP-treated mice was due to a dampened Th1-type immunopathology as indicated by reduced accumulation of T lymphocytes, the major driving forces of T. gondii-induced ileitis <ref type="bibr" target="#b1">[2]</ref>, which were signifi cantly reduced upon NAP application in our study.</s><s>This is supported by Braitch and colleagues demonstrating that NAP suppressed proliferation and activation of T cells in vitro leading to a decrease in pro-infl ammatory cytokine secretion including IFN-γ <ref type="bibr" target="#b17">[18]</ref>.</s><s>In NAP-treated mice, decreased concentrations of pro-infl ammatory mediators could be observed not only in intestinal, but also in extra-intestinal compartments such as liver and spleen.</s><s>This is well in line with in vitro data showing that NAP suppresses the production of proinfl ammatory cytokines such as TNF, IL-6, and IL-12 from murine macrophages <ref type="bibr" target="#b11">[12]</ref> and of NO in cerebral cortical cultures <ref type="bibr" target="#b13">[14]</ref>.</s><s>The pronounced systemic anti-infl ammatory responses observed in serum samples derived from NAPtreated mice in our study is remarkable.</s><s>ADNP is hypothesized to be a secreted protein <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b36">37]</ref> and NAP to exert its immunoregulatory properties in the systemic circulation in a cytokine-like (apocrine or paracrine) fashion, but without a distinct surface receptor <ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>We have very recently investigated the immunomodulatory properties of another neuropeptide, namely, pituitary adenylate cyclase-activating polypeptide (PACAP) in our acute ileitis model.</s><s>As in the present study, synthetic PACAP was able to ameliorate acute small intestinal infl ammation as well as extraintestinal and systemic sequelae by down-regulating Th-1 type immunopathology, reducing oxidative stress and upregulating anti-infl ammatory cytokine responses <ref type="bibr" target="#b37">[38]</ref>.</s></p><p><s>In summary, we show here for the fi rst time that the neuropeptide NAP exerts potent anti-infl ammatory effects in acute ileitis that are not restricted to the intestinal tract but also diminishes extra-intestinal and systemic infl ammatory collateral damages.</s><s>Until now, synthetic NAP (generic name davunetide) has entered phase 3 clinical trials for the treatment of progressive supranuclear palsy <ref type="bibr" target="#b38">[39]</ref>.</s></p><p><s>We conclude that these fi ndings provide novel treatment options of intestinal infl ammatory diseases including IBD.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .Fig. 2 .</head><label>12</label><figDesc><div><p><s>Fig. 1.</s><s>Clinical conditions and small intestinal histopathology in NAP-treated mice following acute ileitis induction.</s><s>In order to induce acute ileitis, C57BL/6j wildtype mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0. Mice were treated either with synthetic NAP (open circles) or placebo (PLC; filled circles).</s><s>Naive, uninfected, and untreated (None; open diamonds) mice served as negative controls.</s><s>(A) Relative loss of body weights between day 7 following ileitis induction and day 0 was determined (in %).</s><s>(B) Histopathological mucosal changes were assessed in ileal H&amp;E stained paraffin sections from respective mice 7 days following peroral T. gondii infection applying a standardized histopathological scoring system.</s><s>(C) T. gondii DNA was determined in ex vivo ileal biopsies at day 7 p.i. Numbers of analyzed mice are given in parentheses.</s><s>Medians (black bars) and significance levels (p-values) determined by Mann-Whitney U test are indicated.</s><s>Data were pooled from three independent experiments</s></p></div></figDesc><graphic coords="3,59.63,68.23,479.06,232.22" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Ileal immune cell responses in NAP-treated mice following acute ileitis induction.</s><s>In order to induce acute ileitis, C57BL/6j wildtype mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0. Mice were treated either with synthetic NAP (open circles) or placebo (PLC; filled circles).</s><s>Naive, uninfected, and untreated (None; open diamonds) mice served as negative controls.</s><s>The average number of cells positive for (A) MPO7 (neutrophils), (B) F4/80 (macrophages and monocytes), (C) CD3 (T lymphocytes), and (D) FOXP3 (regulatory T cells) from at least six high power fields (HPF, 400× magnification) per animal was determined microscopically in immunohistochemically stained ileal paraffin sections derived from mice at day 7 p.i. Numbers of analyzed animals are given in parenthesis.</s><s>Medians (black bars) and level of significance (p-value) determined by Mann-Whitney U test are indicated.</s><s>Data were pooled from three independent experiments</s></p></div></figDesc><graphic coords="4,112.07,184.63,368.48,486.62" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. Ileal pro-inflammatory cytokine secretion in NAP-treated mice following acute ileitis induction.</s><s>In order to induce acute ileitis, C57BL/6j wildtype mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0. Mice were treated either with synthetic NAP (open circles) or placebo (PLC; filled circles).</s><s>Naive, uninfected, and untreated (None; open diamonds) mice served as negative controls.</s><s>(A) MCP-1, (B) TNF, (C) nitric oxide, and (D) IL-6 concentrations were determined in ex vivo biopsies taken from the terminal ileum at day 7 p.i. Numbers of analyzed animals are given in parenthesis.</s><s>Medians (black bars) and level of significance (p-value) determined by Mann-Whitney U test are indicated.</s><s>Data were pooled from three independent experiments</s></p></div></figDesc><graphic coords="5,114.83,206.23,368.48,486.02" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 5 .</head><label>5</label><figDesc><div><p><s>Fig. 5. Pro-inflammatory cytokine secretion in livers of NAP-treated mice following acute ileitis induction.</s><s>In order to induce acute ileitis, C57BL/6j wildtype mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0. Mice were treated either with synthetic NAP (open circles) or placebo (PLC; filled circles).</s><s>Naive, uninfected, and untreated (None; open diamonds) mice served as negative controls.</s><s>(A) MCP-1, (B) TNF, (C) nitric oxide, and (D) IL-6 concentrations were determined in ex vivo biopsies taken from livers at day 7 p.i. Numbers of analyzed animals are given in parenthesis.</s><s>Medians (black bars) and level of significance (p-value) determined by Mann-Whitney U test are indicated.</s><s>Data were pooled from three independent experiments</s></p></div></figDesc><graphic coords="6,111.83,211.99,368.93,479.18" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 6 .</head><label>6</label><figDesc><div><p><s>Fig. 6.</s><s>Pro-inflammatory cytokine secretion in spleens of NAP-treated mice following acute ileitis induction.</s><s>In order to induce acute ileitis, C57BL/6j wildtype mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0. Mice were treated either with synthetic NAP (open circles) or placebo (PLC; filled circles).</s><s>Naive, uninfected, and untreated (None; open diamonds) mice served as negative controls.</s><s>(A) MCP-1, (B) TNF, (C) nitric oxide, and (D) IL-6 concentrations were determined in ex vivo biopsies taken from spleens at day 7 p.i. Numbers of analyzed animals are given in parenthesis.</s><s>Medians (black bars) and level of significance (p-value) determined by Mann-Whitney U test are indicated.</s><s>Data were pooled from three independent experiments</s></p></div></figDesc><graphic coords="7,114.71,237.91,368.93,453.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 7 .</head><label>7</label><figDesc><div><p><s>Fig. 7. Systemic pro-inflammatory cytokine secretion in NAP-treated mice following acute ileitis induction.</s><s>In order to induce acute ileitis, C57BL/6j wildtype mice were perorally infected with 100 cysts of T. gondii ME49 strain on day 0. Mice were treated either with synthetic NAP (open circles) or placebo (PLC; filled circles).</s><s>Naive, uninfected, and untreated (None; open diamonds) mice served as negative controls.</s><s>(A) MCP-1, (B) TNF, (C) IL-12p70, and (D) IL-6 concentrations were determined in serum samples at day 7 p.i. Numbers of analyzed animals are given in parenthesis.</s><s>Medians (black bars) and level of significance (p-value) determined by Mann-Whitney U test are indicated.</s><s>Data were pooled from three independent experiments</s></p></div></figDesc><graphic coords="8,111.83,68.23,368.93,460.22" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Michaela Wattrodt, Ursula Rüschendorf, Ulrike Hagen, Alexandra Bittroff-Leben, Ines Puschendorf, Gernot Reifenberger, and Uwe Lohmann for excellent technical assistance.</s><s>We are grateful to Simone Spieckermann for immunohistochemical staining of paraffi n sections.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Financial disclosure, grant support</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the article.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>Professor Gozes is the Chief Scientifi c Offi cer of Coronis Partners, developing NAP (davunetive).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii</title>
		<author>
			<persName><forename type="first">O</forename><surname>Liesenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Remington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Suzuki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">1184</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="597" to="607" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Immunology of Toxoplasma gondii</title>
		<author>
			<persName><forename type="first">M</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Liesenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">240</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="269" to="285" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Schwartzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Matsuura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kasper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page" from="13955" to="13960" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">TNF-alpha, nitric oxide and IFNgamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii</title>
		<author>
			<persName><forename type="first">O</forename><surname>Liesenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Parkhe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Watanabe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Parasite Immunol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="365" to="376" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Mennechet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rachinel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vandewalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buzoni-Gatel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2988" to="2996" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vossenkamper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Struck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alvarado-Esquivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Went</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3197" to="3207" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections</title>
		<author>
			<persName><forename type="first">D</forename><surname>Buzoni-Gatel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schulthess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Menard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Kasper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Microbiol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="535" to="544" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?</title>
		<author>
			<persName><forename type="first">O</forename><surname>Liesenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="page" from="S96" to="101" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>Suppl 1</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bassan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zamostiano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pinhasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giladi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Perl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurochem</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1283" to="1293" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Cloning and characterization of the human activity-dependent neuroprotective protein</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zamostiano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pinhasov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gelber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Steingart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Seroussi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giladi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="708" to="714" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The femtomolar-acting NAP interacts with microtubules: novel aspects of astrocyte protection</title>
		<author>
			<persName><forename type="first">I</forename><surname>Gozes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Divinski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Alzheimers Dis</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="S37" to="41" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Quintana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zaltzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fernandez-Montesinos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Herrera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gozes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1070</biblScope>
			<biblScope unit="page" from="500" to="506" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Gozes I: A novel peptide prevents death in enriched neuronal cultures</title>
		<author>
			<persName><forename type="first">I</forename><surname>Zemlyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Furman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brenneman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="39" to="43" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide</title>
		<author>
			<persName><forename type="first">O</forename><surname>Ashur-Fabian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Segal-Ruder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Skutelsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brenneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Steingart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giladi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1413" to="1423" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice</title>
		<author>
			<persName><forename type="first">L</forename><surname>Beni-Adani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gozes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Assaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Steingart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brenneman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharmacol Exp Ther</title>
		<imprint>
			<biblScope unit="volume">296</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="57" to="63" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">NAP enhances neurodevelopment of newborn apolipoprotein E-deficient mice subjected to hypoxia</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rotstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bassan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kariv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Speiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gozes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharmacol Exp Ther</title>
		<imprint>
			<biblScope unit="volume">319</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="332" to="339" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">NAP prevents acute cerebral oxidative stress and protects against long-term brain injury and cognitive impairment in a model of neonatal hypoxiaischemia</title>
		<author>
			<persName><forename type="first">S</forename><surname>Greggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>De Paula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>De Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trindade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Rosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Henriques</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Dis</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="152" to="159" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Braitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kawabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nyirenda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Gilles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimmunomodulation</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="120" to="125" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bereswill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Struck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Niebergall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="8785" to="8795" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Jahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Niebergall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Freudenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Blaut</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="941" to="948" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Bereswill S: Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">B</forename><surname>Göbel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Microbiol Immunol (Bp)</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="36" to="43" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bereswill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Otto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">e15099</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Novel murine infection models provide deep insights into the &quot;menage a trois&quot; of Campylobacter jejuni, microbiota and host innate immunity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bereswill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kühl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e20953</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/-mice via Toll-like-receptor-2 and -4 signaling</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kühl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">B</forename><surname>Göbel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page">e40761</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Otto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kühl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">B</forename><surname>Göbel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e35988</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alutis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grundmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tegtmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Böhm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Cell Infect Microbiol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">77</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17</title>
		<author>
			<persName><forename type="first">M</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Danker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Struck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Lohmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Plickert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="3047" to="3059" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The Ki-67 protein: from the known and the unknown</title>
		<author>
			<persName><forename type="first">T</forename><surname>Scholzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gerdes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="311" to="322" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The impact of Toll-like-receptor-9 on intestinal microbiota composition and extra-intestinal sequelae in experimental Toxoplasma gondii induced ileitis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bereswill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kühl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alutis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Möhle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Struck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut Pathog</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">19</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Microbial influences in inflammatory bowel diseases</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Sartor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="577" to="594" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Sartor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1816" to="1819" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Composition of intestinal microbiota in immune-deficient mice kept in three different housing conditions</title>
		<author>
			<persName><forename type="first">C</forename><surname>Thoene-Reineke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Friese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Briesemeister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">B</forename><surname>Göbel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kammertoens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">e113406</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alutis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grundmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tegtmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut Pathog</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">16</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondiiinduced murine ileitis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Dunay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alutis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Möhle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">B</forename><surname>Göbel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">e105120</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Leker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Teichner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Grigoriadis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ovadia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brenneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fridkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1085" to="1092" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Tau and caspase 3 as targets for neuroprotection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Idan-Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ostritsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gozes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Alzheimers Dis</title>
		<imprint>
			<biblScope unit="page">493670</biblScope>
			<date type="published" when="2012">2012. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Furman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Steingart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mandel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Brenneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gozes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron Glia Biol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="193" to="199" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Pituitary adenylate cyclase-activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelae</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Heimesaat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Dunay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schulze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grundmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alutis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e108389</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Boxer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grossman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Knopman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Schneider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="676" to="685" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
